Predictive value of CHADS2 score and modified CHADS score for reoccurrence of atrial fibrillation after radiofrequency catheter ablation
Song-Yun WANG,Zhi-Bing LU,Li-Lei YU,Bing HUANG,Zhuo WANG,Wen-Bo HE,Kai LIAO,Gao-Wa SAREN,Kang YANG,Hong JIANG
DOI: https://doi.org/10.3724/SP.J.1264.2014.00003
2014-01-01
Chinese Journal of Multiple Organ Diseases in the Elderly
Abstract:Objective To determine the value of cardiac failure, hypertension, age, diabetes and stroke 2 (CHADS2) and modified CHADS score to predict the recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation. Methods A total of 93 consecutive patients with nonvalvular AF who received catheter ablation in our department from July 2010 to March 2012 were enrolled in this study. They were all followed up for at least 12 months. Electrocardiography or 24-hour Holter monitoring was conducted in these patients in 1, 3, 6, 9, and 12 months after ablation. They were divided into AF recurrence group (n=40) and AF recurrence-free group (n=53) according to clinical manifestations and electrocardiographic results. Univariate and multivariate analyses were conducted to find which variable was related with the risk of AF recurrence. Results There were 35 cases (37.65%) of persistent AF out of 93 AF patients, and 40 of them (43.01%) had AF recurrence in 12 months after ablation. Univariate analysis revealed that average age (P<0.01), age>70 years (P<0.05), medical history (P<0.05), type of AF (P<0.01), left atrial diameter (LAD, P<0.001), left ventricular ejection fraction (P<0.05), hematocrit (P<0.05), accompanied with congestive heart failure (P<0.05), hypertension (P<0.01), diabetes (P<0.05), prior stroke or transient cerebral ischemic attack (P<0.05), post-operative administration of angiotensin converting enzyme inhibitor or angiotensin Ⅱ receptor blocker (ACEI/ARB, P<0.01) or class Ⅲ antiarrhythmic drugs (P<0.05),` and CHADS2 score ≥1 (P<0.001) were significantly related with the outcome of nonvalvular AF after ablation. Logistic analysis showed that medical history (OR=1.16, P=0.020), LAD (OR=1.17, P=0.025), type of AF (OR=3.34, P=0.050), and CHADS2 score≥1 (OR=5.93, P=0.019) were independent predictors of AF recurrence after ablation. CHADS2 score ≥2 (OR=5.42, P=0.028), modified CHADS score ≥1 (OR=6.64, P=0.015) and modified CHADS score ≥2 (OR=7.32, P=0.002) were also the independent risk factors of recurrence. Cut-off analysis showed that both CHADS2 score and modified CHADS score ≥1 showed the highest predictive value for AF recurrence. There was no significant difference in the sensitivity, specificity, area under the receiver’s operating characteristic (AUC) curve for the 2 scores both ≥1 [0.775 vs 0.800, 0.358 vs 0.377, 0.708(95%CI 0.601-0.806) vs 0.711(95%CI 0.605-0.818), all P>0.05]. Conclusion Medical history, LAD, type of AF, CHADS2 score ≥1, CHADS2 score ≥2, modified CHADS score ≥1, and modified CHADS score ≥2 are independent predictors of the recurrence of AF after ablation. And the modified CHADS score has similar value as CHADS2 score in the predicton.